Lexeo Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Lexeo Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2022 to Q2 2024.
  • Lexeo Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $35K, a 34% decline year-over-year.
  • Lexeo Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $174K.
  • Lexeo Therapeutics, Inc. annual Interest Expense for 2023 was $205K, a 125% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $174K $35K -$18K -34% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $192K $37K -$13K -26% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $205K $50K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $52K +$23K +79.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-12-11
Q2 2023 $53K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $50K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $29K Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.